Referencia número: HY-N0114A

(±)-Evodiamine

1 Cited Publications

Revisión del cliente

Based on 1 publication(s) in Google Scholar

(±)-Evodiamine, a quinazolinocarboline alkaloid, is a Top1 inhibitor. Evodiamine exhibits anti-inflammatory, antiobesity, and antitumor effects. (±)-Evodiamine inhibits the proliferation of a wide variety of tumor cells by inducing their apoptosis.

Para uso exclusivo en investigación. No vendemos a pacientes.

Pureza: 99.74%
No. CAS: 518-18-3
Fòrmula: C₁₉H₁₇N₃O
Peso molecular:303.36

Almacenamiento:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month

(±)-Evodiamine Chemical Structure

No. CAS: 518-18-3

Tamaño

Precio

Stock

Cantidad

Amount: USD 0.00

* Seleccione Cantidad antes de agregar artículos.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

HY-N0114AR

(±)-Evodiamine (Standard)

Actividad biológica
- Descripciòn
- IC₅₀ & Target
- Cellular Effect
Chemical Information
Publications (1)
Solvente y solubilidad
- In Vitro
- In Vivo
Pureza y Documentación
Referencias
Help & FAQs
Classifications
Bioz

Actividad biológica

Descripciòn

IC₅₀ & Target^[1]

Top1

Ver todos los productos específicos de isoformas Topoisomerase :

Cellular Effect

Cell Line	Type	Value	Description	References
A549	IC₅₀	0.98 μM Compound: 1	Antiproliferative activity against human A549 cells after 72 hrs by MTT assay Antiproliferative activity against human A549 cells after 72 hrs by MTT assay	[PMID: 27178387]
A549	IC₅₀	1.3 μM Compound: Fig 1A, Cpd 4	Antiproliferative activity against human A549 cells Antiproliferative activity against human A549 cells	[PMID: 38897138]
A549	IC₅₀	77.24 μM Compound: 3; Evo	Antiproliferative activity against human A549 cells assessed as inhibition rate incubated for 72 hrs by MTT assay Antiproliferative activity against human A549 cells assessed as inhibition rate incubated for 72 hrs by MTT assay	[PMID: 34844412]
Bel-7402	IC₅₀	1.19 μM Compound: 1	Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay	[PMID: 29635169]
Bel-7402	IC₅₀	1.23 μM Compound: 1	Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay	[PMID: 27178387]
BGC-823	IC₅₀	1.16 μM Compound: 1	Antiproliferative activity against human BGC823 cells after 72 hrs by MTT assay Antiproliferative activity against human BGC823 cells after 72 hrs by MTT assay	[PMID: 27178387]
Caco-2	IC₅₀	2.73 μM Compound: 1	Antiproliferative activity against human Caco2 cells after 72 hrs by MTT assay Antiproliferative activity against human Caco2 cells after 72 hrs by MTT assay	[PMID: 29635169]
CHO	EC₅₀	0.86 μM Compound: 1	Agonist activity at rat TRPV1 expressed in CHO cells assessed as induction of 45Ca2+ uptake measured after 5 mins by scintillation counting method Agonist activity at rat TRPV1 expressed in CHO cells assessed as induction of 45Ca2+ uptake measured after 5 mins by scintillation counting method	[PMID: 27159637]
GES1	IC₅₀	>30 μM Compound: EVO	Antiproliferative activity against human GES1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Antiproliferative activity against human GES1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 37099835]
HCCLM9	IC₅₀	1.63 μM Compound: 1; Evo	Antiproliferative activity against human HCCLM9 cells assessed as reduction in cell growth incubated for 48 hrs by CCK-8 assay Antiproliferative activity against human HCCLM9 cells assessed as reduction in cell growth incubated for 48 hrs by CCK-8 assay	[PMID: 36549115]
HCCLM9	IC₅₀	9.27 μM Compound: EVO	Antiproliferative activity against human HCCLM9 cells treated for 72 hrs by MTT assay Antiproliferative activity against human HCCLM9 cells treated for 72 hrs by MTT assay	[PMID: 35639640]
HCT-116	IC₅₀	32.67 μM Compound: 3; Evo	Antiproliferative activity against human HCT-116 cells assessed as inhibition rate incubated for 72 hrs by MTT assay Antiproliferative activity against human HCT-116 cells assessed as inhibition rate incubated for 72 hrs by MTT assay	[PMID: 34844412]
HEK293	EC₅₀	0.1 μM Compound: 1	Partial antagonist activity at rat TRPV1 expressed in HEK293 cells assessed as capsaicin EC50 for induction of channel current at 0.1 uM at -60 mV holding potential by whole-cell patch clamp method (Rvb = 0.06 uM) Partial antagonist activity at rat TRPV1 expressed in HEK293 cells assessed as capsaicin EC50 for induction of channel current at 0.1 uM at -60 mV holding potential by whole-cell patch clamp method (Rvb = 0.06 uM)	[PMID: 27159637]
HEK293	EC₅₀	0.18 μM Compound: 1	Partial antagonist activity at rat TRPV1 expressed in HEK293 cells assessed as capsaicin EC50 for induction of channel current at 0.6 uM at -60 mV holding potential by whole-cell patch clamp method (Rvb = 0.06 uM) Partial antagonist activity at rat TRPV1 expressed in HEK293 cells assessed as capsaicin EC50 for induction of channel current at 0.6 uM at -60 mV holding potential by whole-cell patch clamp method (Rvb = 0.06 uM)	[PMID: 27159637]
HEK293	EC₅₀	0.33 μM Compound: 1	Partial antagonist activity at rat TRPV1 expressed in HEK293 cells assessed as capsaicin EC50 for induction of channel current at 1 uM at -60 mV holding potential by whole-cell patch clamp method (Rvb = 0.06 uM) Partial antagonist activity at rat TRPV1 expressed in HEK293 cells assessed as capsaicin EC50 for induction of channel current at 1 uM at -60 mV holding potential by whole-cell patch clamp method (Rvb = 0.06 uM)	[PMID: 27159637]
HEK293	EC₅₀	0.6 μM Compound: 1	Agonist activity at rat TRPV1 channel expressed in HEK293 cells assessed as induction of channel current at -60 mV holding potential by whole-cell patch-clamp method Agonist activity at rat TRPV1 channel expressed in HEK293 cells assessed as induction of channel current at -60 mV holding potential by whole-cell patch-clamp method	[PMID: 27159637]
HEK293	EC₅₀	2.38 μM Compound: 1	Partial antagonist activity at rat TRPV1 expressed in HEK293 cells assessed as capsaicin EC50 for induction of channel current at 10 uM at -60 mV holding potential by whole-cell patch clamp method (Rvb = 0.06 uM) Partial antagonist activity at rat TRPV1 expressed in HEK293 cells assessed as capsaicin EC50 for induction of channel current at 10 uM at -60 mV holding potential by whole-cell patch clamp method (Rvb = 0.06 uM)	[PMID: 27159637]
HEK293	IC₅₀	>100 μM Compound: 3; Evo	Antiproliferative activity against HEK293 cells assessed as inhibition rate incubated for 72 hrs by MTT assay Antiproliferative activity against HEK293 cells assessed as inhibition rate incubated for 72 hrs by MTT assay	[PMID: 34844412]
HEK293	IC₅₀	0.44 μM Compound: 1	Partial antagonist activity at rat TRPV1 expressed in HEK293 cells assessed as inhibition of capsaicin-induced inward current at -60 mV holding potential pretreated for 180 secs prior to capsaicin addition in presence of extracellular calcium by whole-cel Partial antagonist activity at rat TRPV1 expressed in HEK293 cells assessed as inhibition of capsaicin-induced inward current at -60 mV holding potential pretreated for 180 secs prior to capsaicin addition in presence of extracellular calcium by whole-cel	[PMID: 27159637]
HepG2	IC₅₀	2.67 μM Compound: EVO	Antiproliferative activity against human HepG2 cells treated for 72 hrs by MTT assay Antiproliferative activity against human HepG2 cells treated for 72 hrs by MTT assay	[PMID: 35639640]
HepG2	IC₅₀	21.52 μM Compound: 1; Evo	Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by CCK-8 assay Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by CCK-8 assay	[PMID: 36549115]
HepG2	IC₅₀	9.32 μM Compound: 1	Antiproliferative activity against human HepG2 cells treated for 24 hrs measured after 72 hrs by MTT assay Antiproliferative activity against human HepG2 cells treated for 24 hrs measured after 72 hrs by MTT assay	[PMID: 29037951]
HGC-27	IC₅₀	>30 μM Compound: EVO	Antiproliferative activity against human HGC-27 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Antiproliferative activity against human HGC-27 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 37099835]
HGC-27	IC₅₀	2.28 μM Compound: 1; Evo	Antiproliferative activity against human HGC-27 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay Antiproliferative activity against human HGC-27 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay	[PMID: 36549115]
HGC-27	IC₅₀	2.28 μM Compound: Evo	Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 35728506]
HL-60	IC₅₀	1.36 μM Compound: 1	Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay	[PMID: 29635169]
HL-60	IC₅₀	1.39 μM Compound: 1	Antiproliferative activity against human HL60 cells treated for 24 hrs measured after 72 hrs by MTT assay Antiproliferative activity against human HL60 cells treated for 24 hrs measured after 72 hrs by MTT assay	[PMID: 29037951]
Huh-7	IC₅₀	0.78 μM Compound: 1; Evo	Antiproliferative activity against human Huh-7 cells assessed as reduction in cell viability incubated for 48 hrs by CCK-8 assay Antiproliferative activity against human Huh-7 cells assessed as reduction in cell viability incubated for 48 hrs by CCK-8 assay	[PMID: 36549115]
Huh-7	IC₅₀	2.18 μM Compound: EVO	Antiproliferative activity against human Huh-7 cells treated for 72 hrs by MTT assay Antiproliferative activity against human Huh-7 cells treated for 72 hrs by MTT assay	[PMID: 35639640]
L02	IC₅₀	0.34 μM Compound: 1	Antiproliferative activity against human L02 cells after 72 hrs by MTT assay Antiproliferative activity against human L02 cells after 72 hrs by MTT assay	[PMID: 27178387]
L02	IC₅₀	3.95 μM Compound: EVO	Antiproliferative activity against human L02 cells treated for 72 hrs by MTT assay Antiproliferative activity against human L02 cells treated for 72 hrs by MTT assay	[PMID: 35639640]
LoVo	IC₅₀	24.19 μM Compound: EVO	Antiproliferative activity against human LoVo cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Antiproliferative activity against human LoVo cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 37099835]
MCF-10A	IC₅₀	>100 μM Compound: 3; Evo	Antiproliferative activity against human MCF-10A cells assessed as inhibition rate incubated for 72 hrs by MTT assay Antiproliferative activity against human MCF-10A cells assessed as inhibition rate incubated for 72 hrs by MTT assay	[PMID: 34844412]
MCF7	IC₅₀	0.3 μM Compound: 48	Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay	[PMID: 36375335]
MCF7	IC₅₀	28.53 μM Compound: 1	Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay	[PMID: 29635169]
MDA-MB-231	IC₅₀	13.3 μM Compound: 3; Evo	Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition rate incubated for 72 hrs by MTT assay Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition rate incubated for 72 hrs by MTT assay	[PMID: 34844412]
MDA-MB-435	IC₅₀	6.3 μM Compound: 3; Evo	Antiproliferative activity against human MDA-MB-435 cells assessed as inhibition rate incubated for 72 hrs by MTT assay Antiproliferative activity against human MDA-MB-435 cells assessed as inhibition rate incubated for 72 hrs by MTT assay	[PMID: 34844412]
MGC-803	IC₅₀	1.37 μM Compound: Evo	Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 35728506]
MGC-803	IC₅₀	12 μM Compound: Fig 1A, Cpd 4	Antiproliferative activity against human MGC-803 cells Antiproliferative activity against human MGC-803 cells	[PMID: 38897138]
MGC-803	IC₅₀	8.52 μM Compound: EVO	Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 37099835]
NCI/ADR-RES	IC₅₀	0.47 μM Compound: 48	Antiproliferative activity against human MCF7ADR cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay Antiproliferative activity against human MCF7ADR cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay	[PMID: 36375335]
NCI-H1650	IC₅₀	4.53 μM Compound: 48	Antiproliferative activity against human NCI-H1650 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay Antiproliferative activity against human NCI-H1650 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay	[PMID: 36375335]
NCI-H1975	IC₅₀	5.59 μM Compound: 48	Antiproliferative activity against human NCI-H1975 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay Antiproliferative activity against human NCI-H1975 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay	[PMID: 36375335]
PBMC	IC₅₀	20.96 μM Compound: 1	Antiproliferative activity against human PBMC cells after 72 hrs by MTT assay Antiproliferative activity against human PBMC cells after 72 hrs by MTT assay	[PMID: 29635169]
PBMC	IC₅₀	22.87 μM Compound: 1	Antiproliferative activity against human PBMC treated for 24 hrs measured after 72 hrs by MTT assay Antiproliferative activity against human PBMC treated for 24 hrs measured after 72 hrs by MTT assay	[PMID: 29037951]
PC-3	IC₅₀	13.97 μM Compound: 1	Antiproliferative activity against human PC3 cells treated for 24 hrs measured after 72 hrs by MTT assay Antiproliferative activity against human PC3 cells treated for 24 hrs measured after 72 hrs by MTT assay	[PMID: 29037951]
RKO	IC₅₀	29.65 μM Compound: EVO	Antiproliferative activity against human RKO cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Antiproliferative activity against human RKO cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 37099835]
SGC-7901	IC₅₀	17.71 μM Compound: EVO	Antiproliferative activity against human SGC-7901 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Antiproliferative activity against human SGC-7901 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 37099835]
SGC-7901	IC₅₀	3.6 μM Compound: Evo	Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay	[PMID: 35728506]
SGC-7901	IC₅₀	6.93 μM Compound: 1	Antiproliferative activity against human SGC7901 cells after 72 hrs by MTT assay Antiproliferative activity against human SGC7901 cells after 72 hrs by MTT assay	[PMID: 29635169]
SK-HEP1	IC₅₀	2.92 μM Compound: EVO	Antiproliferative activity against human SK-HEP1 cells treated for 72 hrs by MTT assay Antiproliferative activity against human SK-HEP1 cells treated for 72 hrs by MTT assay	[PMID: 35639640]
SMMC-7721	IC₅₀	3.04 μM Compound: EVO	Antiproliferative activity against human SMMC-7721 cells treated for 72 hrs by MTT assay Antiproliferative activity against human SMMC-7721 cells treated for 72 hrs by MTT assay	[PMID: 35639640]
SW480	IC₅₀	>30 μM Compound: EVO	Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 37099835]
SW480	IC₅₀	10 μM Compound: Fig 1A, Cpd 4	Antiproliferative activity against human SW480 cells Antiproliferative activity against human SW480 cells	[PMID: 38897138]
THP-1	IC₅₀	3.37 μM Compound: 1	Antiproliferative activity against human THP1 cells treated for 24 hrs measured after 72 hrs by MTT assay Antiproliferative activity against human THP1 cells treated for 24 hrs measured after 72 hrs by MTT assay	[PMID: 29037951]

Chemical Information

No. CAS 518-18-3
Appearance Solid
Peso molecular 303.36
Fòrmula C₁₉H₁₇N₃O
Color Off-white to light brown
SMILES

O=C1C2=CC=CC=C2N(C)C(N1CC3)C4=C3C5=CC=CC=C5N4
Structure Classification
- Alkaloids
- Indole Alkaloids
Initial Source
Envío

Room temperature in continental US; may vary elsewhere.

Almacenamiento

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Publications (1)

All

Sort by:

Journal Impact Factor

J Chromatogr A

Stereoselectivity of evodiamine enantiomers in neuroprotective activity, pharmacokinetics and the ability across the blood-brain barrier. [Abstract]

2025 Feb 22:1743:465658. PMID: 39808905

Solvente y solubilidad

In Vitro:

DMSO : 10 mg/mL (32.96 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

3.2964 mL

16.4821 mL

32.9641 mL

5 mM

0.6593 mL

3.2964 mL

6.5928 mL

10 mM

0.3296 mL

1.6482 mL

3.2964 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Calculadora de molaridad

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculadora de dilución

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 90% Corn Oil

Solubility: ≥ 1 mg/mL (3.30 mM); Clear solution

This protocol yields a clear solution of ≥ 1 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (10.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

Pureza y Documentación

Select Batch:

Pureza: 99.98%

Assay: 99.98%

ee.: 99.98%

Ficha de datos (276 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Instrucciones de manejo (2659 KB)

Referencias

[1]. Dong G, et, al. New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations. J Med Chem. 2012 Sep 13;55(17):7593-613. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	3.2964 mL	16.4821 mL	32.9641 mL	82.4103 mL
	5 mM	0.6593 mL	3.2964 mL	6.5928 mL	16.4821 mL
	10 mM	0.3296 mL	1.6482 mL	3.2964 mL	8.2410 mL
	15 mM	0.2198 mL	1.0988 mL	2.1976 mL	5.4940 mL
	20 mM	0.1648 mL	0.8241 mL	1.6482 mL	4.1205 mL
	25 mM	0.1319 mL	0.6593 mL	1.3186 mL	3.2964 mL
	30 mM	0.1099 mL	0.5494 mL	1.0988 mL	2.7470 mL

Keywords

(±)-Evodiamine

1 Cited Publications

100 mg Obtener un presupuesto

Subscribe to the

MedChemExpress

Newsletter

Nombre del producto:
Referencia número:
Cantidad:
MCE Japan Authorized Agent:

Nombre del producto:
No. CAS:
Species:
Pureza:
Cantidad:

(±)-Evodiamine

(±)-Evodiamine (Standard)

Publications Citing Use of MedChemExpress (MCE) (±)-Evodiamine

Ver todos los productos específicos de isoformas Topoisomerase

Actividad biológica

Chemical Information

Publications (1)

Solvente y solubilidad

Pureza y Documentación

Referencias

Help & FAQs

Complete Stock Solution Preparation Table

(±)-Evodiamine Related Classifications

HY-N0114A Related Classifications